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Background & Aims: The proteasome is a major cel-
lular proteinase. Its activity is modulated by cellular
oxidants. Hepatitis C core protein and ethanol expo-
sure both cause enhanced oxidant generation. The
aim was to investigate whether core protein, by its
ability to generate oxidants, alters proteasome activ-
ity and whether these alterations are further affected
by ethanol exposure. Methods: These interactions
were examined in Huh-7 cell lines that expressed in-
ducible HCV core protein and/or constitutive cyto-
chrome P450 2E1 (CYP2E1) and as purified com-
ponents in a cell-free system. Chymotrypsin-like
proteasome activity was measured fluorometrically.
Results: Proteasome activity in core-positive 191-20
cells was 20% higher than that in core-negative cells
and was enhanced 3-fold in CYP2E1-expressing L14
cells. Exposure of core-positive cells to glutathione
ethyl ester, catalase, or the CYP2E1 inhibitor diallyl
sulfide partially reversed the elevation of proteasome
activity in core-positive cells, whereas ethanol expo-
sure suppressed proteasome activity. The results in-
dicate that proteasome activity was up-regulated by
low levels of core-induced oxidative stress but down-
regulated by high levels of ethanol-elicited stress.
These findings were partially mimicked in a cell-free
system. Addition of core protein enhanced the pepti-
dase activity of purified 20S proteasome containing
the proteasome activator PA28 and was further po-
tentiated by addition of liver mitochondrial and/or
microsome fractions. However, proteasome activa-
tion was significantly attenuated when fractions were
obtained from ethanol-fed animals. Conclusions:
HCV core protein interacts with PA28, mitochon-
drial, and endoplasmic reticulum proteins to cause
low levels of oxidant stress and proteasome activa-
tion, which is dampened during ethanol metabolism
when oxidant generation is higher.
The proteasome is the major cellular protein-degrad-ing enzyme that degrades 80% of intracellular pro-
teins. The enzyme is crucial for cell survival because it
plays a pivotal role in destroying not only normal but
also damaged proteins. By degrading short-lived signal
transduction factors, the proteasome regulates signal
transduction events and the inflammatory response.1,2 In
the immune response, the proteasome cleaves antigenic
proteins to generate peptides for major histocompatibil-
ity complex (MHC) class I-restricted antigen presenta-
tion.3
Proteasome function is regulated by the levels of in-
tracellular oxidants. In liver cells, the proteasome is con-
tinuously exposed to oxidants because of mitochondrial
electron transport as well as high expression levels of
cytochrome P4502E1 (CYP2E1). Multiple agents, includ-
ing viral proteins and ethanol, enhance oxidant genera-
tion in the liver.
Hepatitis C virus (HCV) core protein plays an impor-
tant role in HCV infection pathogenesis. The viral pro-
tein is known to induce oxidative stress by its ability to
associate with the outer membrane of the mitochon-
drion. This interaction increases Ca2 entry, mitochon-
drial superoxide production, and subsequently elevates
generation of reactive oxygen species (ROS) by mitochon-
drial electron transport complex I. This results in a de-
creased mitochondrial glutathione (GSH) and in mito-
chondrial depolarization, which can be augmented by
simultaneous endoplasmic reticulum (ER) oxidative
stress.4,5 The ability of core protein to increase oxidant
production has been reported in isolated mitochondria,
in cells expressing core protein, in full-length HCV rep-
licon, and in liver mitochondria derived from HCV trans-
genic mice.5,6 These effects of core protein are enhanced
in CYP2E1-expressing cells and are further potentiated by
alcohol exposure.4–7 Because core protein induces oxi-
dant formation and because the proteasome is sensitive
to their levels in cells,8–10 we postulated that core protein
up-regulates proteasome activity. Further induction of
oxidative stress by ethanol exposure may revise the effects
Abbreviations used in this paper: CYP2E1, cytochrome P450 2E1;
DAS, diallyl sulfide; ER, endoplasmic reticulum; GSH-EE, glutathione
ethyl ester; HCV, hepatitis C virus; HSP, heat shock protein; ROS,
reactive oxygen species; t-BOOH, t-butyl hydroperoxide.
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of core protein on proteasome because ethanol metabo-
lism suppresses proteasome activity.11,12 Suppression of
proteasome activity may enhance disease progression in
HCV-infected, alcohol-consuming patients because it is
known that ethanol consumption exacerbates the clinical
course of HCV infection in these individuals.13,14 To date,
specific interactions between proteasome and HCV core
protein and the effects of ethanol on these interactions
have not been investigated. Hence, we sought to deter-
mine specific interactions between HCV core protein and
proteasome activity in vitro and in cultured hepatoma
cells that have inducible expression of HCV core protein
and in cells with and without constitutive expression of
CYP2E1.
Materials and Methods
Reagents and Media
High-glucose Dulbecco’s modified Eagle medium
(DMEM), F12, blasticidin S, and fetal bovine serum (FBS)
were purchased from Invitrogen (Carlsbad, CA). G418
and antibody to PA28 were from Calbiochem (La Jolla,
CA). MeO-Suc-Phe-Leu-Phe-AFC (FLF-AFC) was from
MP Biomedicals (Aurora, OH). Other reagents, all of
analytical grade quality, were from Sigma Chemical Co
(St Louis, MO). PA28 was a gift from Dr George De-
Martino, University of Texas Southwestern Medical Cen-
ter, Dallas, TX.
Cell Lines
Huh7 cells, which express core protein under a
tetracycline-repressible promoter, either in CYP2E1-non-
expressing (191-20) or in CYP2E1-expressing (L-14) cell
lines were used in this study. Both cell lines expressed
core protein in the absence of tetracycline after 4 days of
tetracycline withdrawal and exhibited no core expression
in its presence at 2 g/mL (Figure 1A). Both core protein
and CYP2E1 were detected by Western blot using mono-
clonal anti-HCV core (Affinity BioReagents, Golden, CO)
or anti-CYP2E1 (Calbiochem, La Jolla, CA), respectively.
Culture conditions were as described.7
Cell Treatments
Hepatoma cells were plated onto 96-well black
plates with clear bottoms at a density of 5  103 cells/
well and were incubated in a 1:1 mixture of DMEM/F12,
media supplemented with 5% FBS, penicillin-streptomy-
cin, and selective antibiotics (200 g G418/mL for the
core protein and 4 g blasticidin S/mL for the CYP2E1
expression). After overnight attachment, cells were
treated as described in the text and Figure legends.
Proteasome Purification
20S proteasome was purified from rat livers ac-
cording to the procedure described.15 The purification
steps included a high-speed (105,000g) centrifugation for
60 minutes followed by a 16-hour centrifugation of the
Figure 1. (A) Expression of core protein in tet and tet Huh7 cells.
HCV core protein was detected in cell lysates by Western blot, and
-actin was used as a loading control: 1. 191-20 tet cells; 2. 191-20
tet cells; 3. L-14 tet cells; 4. L-14 tet cells; 5. Recombinant HCV
core protein. (B) Proteasome activity in 191-20, L-14, and Huh7 cells
before and after tetracycline treatment. All 3 cell lines were treated or
not with 2 g tetracycline/ml for 4 days. Core protein was detected only
in cell lysates of tet 191-20 and L-14 cells by Western blot (insert
above each bar). Proteasome activity is expressed as percent of con-
trol. Percent of control is calculated as (proteasome activity in all exper-
imental readings expressed as (nmol AFC/g DNA divided by nmol
AFC/g DNA proteasome activity in untreated tet cells) 100%. Data
are mean values  SD from 3 experiments. *Indicates a significant
difference (P .05) between tet control cells and other treatments. (C)
Proteasome activity in 191-20 cells. Tetracycline-untreated cells were
treated with 5 mmol/L GSH-EE, 20 mmol/L N-acetyl cysteine (NAC), or
1000 U catalase for 24 hours. Proteasome activity was detected by in
situ assay and compared with that in 191-20 tetracycline-treated cells.
Data from 4 independent experiments are expressed as percent pro-
teasome activity in control in tetracycline-untreated cells. *Indicates a
significant difference (P  .05) between tet control cells and other
treatments. (D) Proteasome activity in L-14 cells. L-14 cells were treated
just as described in A with 20 mol/L DAS and 100 mol/L uric acid for
24 hours. Data from 4 independent experiments are expressed as
percent of control proteasome activity in tetracycline-untreated cells.
*Indicates a significant difference between tet control cells and other
treatments.
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cytosol at 52,000g, DEAE-Sepharose chromatography of
the resuspended proteasome pellet, and hydrophobic in-
teraction chromatography on a phenyl-sepharose col-
umn. In addition to the above-described purification, the
residual enzyme remaining in high-speed supernatant
fraction (which was enriched with PA28) was purified as
described.16
HCV Core Protein Purification
Cloning, expression, and purification of HCV core
protein were performed as described by Kunkel et al.17,18
Briefly, HCV core residues 1 to 179 (HCVC 179) derived
from the AG94 isolate of genotype 1a sequence was
amplified by polymerase chain reaction (PCR) and cloned
into a pET30a expression vector (Novagen, Gillstown,
NJ). Core protein was expressed by transforming Esche-
richia coli BL21 (DE3) cells with the expression vector.
Expression was induced by addition of 1 mmol/L isopro-
pyl--D thiogalactopyranoside. The cells were solubilized
by sonication. Lysates were then diluted with 8 mol/L
urea and incubated overnight at 4°C with 50 mmol/L
dithiothreitol. The supernatant was applied to a cation-
exchange column (Poros 20 CM) preequilibrated with
0.25 mol/L HEPES, pH 7.0, 8 mol/L urea, and 1.5 mol/L
NaCl. Each fraction was separated by SDS-PAGE, and the
gels were stained with coomassie blue to identify HCVC
179, which was found in a single peak eluting around 650
mmol/L NaCl. These fractions were subsequently sub-
jected to reverse-phase, high-pressure liquid chromatog-
raphy (YMC-ODS column; reverse-phase, 150  4.6 mm)
and eluted with a linear gradient of 20 mmol/L sodium-
phosphate-methanol, pH 3.0. Fractions were analyzed as
describe above. Eluted fractions containing core protein
were pooled and dialyzed overnight at 4°C against re-
folding buffer (20 mmol/L Tris [pH 7.0], 100 mmol/L
NaCl). Proteinase inhibitors were added to the dialyzed
sample (50 mol/L leupeptin, 1 mol/L pepstatin A, and
0.5 mmol/L phenylmethylsulfonyl fluoride). The homo-
geneity of purified core protein was determined by SDS-
PAGE and estimated to 98%. Its identity was confirmed
by immunoblot using a mouse monoclonal antibody to
HCV core protein (Affinity BioReagents).
Mitochondrial Isolation
This was performed according to the procedure of
Korenaga et al.6 The mitochondrial fractions were pre-
pared from livers of C57Bl/6 mice fed the Lieber DeCarli
control or ethanol diet for 3 weeks. Briefly, liver tissue
was rinsed with ice-cold phosphate-buffered saline and
lysed by 20 strokes in a Dounce homogenizer, in 40
mmol/L Tris-HCl, 1 mmol/L EDTA, 150 mmol/L NaCl,
(pH 7.4). Homogenates were subjected to low-speed cen-
trifugation, and mitochondrial pellets were obtained by
centrifugation at 10,000g for 10 minutes and then were
resuspended in 200 mmol/L mannitol, 70 mmol/L
EDTA, 10 mmol/L HEPES (pH 7.5). Alternatively, mito-
chondria were prepared as described.19 Contamination of
mitochondria with less than 5% of cytosol was detected.
The latter was determined by the activity of lactate de-
hydrogenase in the mitochondrial preparation compared
with that in cytosol.
Microsome Isolation
Microsomes were isolated from livers of control
and ethanol-fed mice following the fractionation proce-
dure previously published.19
Proteasome Activity
Proteasome chymotrypsin-like activity was de-
tected in situ (intact cells) by measuring hydrolysis of the
membrane-permeable substrate, methoxy-succinyl-phe-
leu-phe-7-amido-4-trifluoromethyl coumarin (MeO-Suc-
FLF-AFC).20 To compare and combine the results of
several experiments, for which we use different cell pas-
sages, proteasome activity expressed as nmol AFC/g
DNA in treated samples was divided by proteasome ac-
tivity in nmol AFC/g DNA in control sample, and this
ratio was multiplied by 100%. In vitro assay of chymo-
trypsin-like activity purified proteasome was performed
using the fluorogenic substrate Suc-LLVY-AMC. Briefly,
the latter reaction was run in black 96-well plates, at 200
L/well, containing 0.1 mol/L Tris-HCl (pH 7.5) and 13
mol/L Suc-LLVY-AMC substrate. After 15- to 60-
minute incubation at 37°C, the reaction product, AMC,
was detected fluorometrically on a plate reader (Victor 3;
Perkin Elmer, Shelton, CT), (excitation, 355 nm; emis-
sion, 460 nm). Enzyme specific activity is expressed as
nmol AMC/mg protein.
In Vitro Incubations
Purified 20S proteasome (50 g protein/mL) in
0.1 mmol/L Tris-HCl (pH 7.5) was incubated for 10
minutes with increasing quantities of core/mitochon-
drial mixture. The ratio of core protein to mitochondrial
protein in the incubation mixture was always maintained
at 1:100,000. Thus, the ratio of core protein to mitochon-
drial proteins used for these in vitro experiments was
comparable with those reported in HCV core protein-
expressing mice.6 We tested the 20S proteasome activity
using 100, 200, or 300 pg core protein using a corre-
sponding amount of mitochondrial protein (ie, 10, 20,
and 30 g mitochondrial protein, respectively) in the
incubation mixture. The same mass quantities of micro-
somal proteins were also used. After incubation, the mix-
tures were assayed for proteasome chymotrypsin-like ac-
tivity.
Statistical Analyses
Data are expressed as mean values  standard
deviation. Multiple comparisons for significance were
determined by 1-way ANOVA, using a Tukey post hoc
test. Comparison between 2 groups used Student t test. A
probability value of .05 or less was considered significant.
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Results
Differential Proteasome Activity in Core
(tet) and Core (tet) Cells
Proteasome activity was significantly higher in
both CYP2E1-negative 191-20 cells and CYP2E1-positive
L-14 cells that expressed core protein in the absence of
tetracycline as compared with the same cells in the pres-
ence of tetracycline. Proteasome chymotrypsin-like activ-
ity was 20% higher in core-positive 191-20 cells compared
with core-negative 191-20 cells. This activity was 60%
higher in the constitutively expressing CYP2E1 core-pos-
itive L-14 cells compared with the same cells that do not
express core protein (Figure 1B). These results clearly
indicated an association between HCV core expression
and proteasome activity. Tetracycline by itself had no
effect on proteasome activity. This was confirmed using
the parental core nonexpressing Huh7 cells that were
similarly treated with tetracycline (Figure 1B).
Because expression of HCV core protein has been
shown to generate intracellular oxidants,7 we tested the
effect of various antioxidants on in situ proteasome ac-
tivity in both 191-20 and L-14 cells. The addition of
glutathione ethyl ester (GSH-EE), N-acetyl cysteine, uric
acid, diallyl sulfide (DAS), or catalase to the extracellular
medium of core-protein cells caused a decrease in pro-
teasome activity that approached the activity level in the
core-negative cells (Figure 1C and D).
Differential Effects of Ethanol Treatment in
191-20 and L-14 Cells
In core-negative and core-positive 191-20 cells,
treatment with 50 mmol/L ethanol for 72 hours did not
affect proteasome activity (data not shown). However,
exposure of CYP2E1-positive L-14 cells to ethanol sup-
pressed proteasome activity by 33% in the presence of
core protein (Figure 2A). Suppression of proteasome ac-
tivity by ethanol in core-positive cells was blocked by
simultaneous exposure to DAS, catalase, or GSH-EE (Fig-
ure 2B).
Biphasic Response of 20S Proteasome to
T-butyl Hydroperoxide
To provide an explanation for the observed differ-
ential regulation of proteasome activity by core protein,
we tested whether the proteasome activity is affected by
various doses of the oxidant t-butyl hydroperoxide (t-
BOOH). Core-positive, CYP2E1-negative 191-20 cells
were treated with increasing concentrations of t-BOOH
(10 mol/L to 100 mol/L) for 5 hours, and in situ
proteasome activity was measured. Ten mmol/L t-BOOH
increased proteasome activity in these cells by 75%, 30
mol/L t-BOOH had no significant effect, and 50 and
100 mol/L t-BOOH completely abolished enzyme activ-
ity (Figure 3). We had previously reported a similar bi-
phasic regulation of proteasome in HepG2 cells exposed
to the peroxynitrite donor SIN-1, which elevated protea-
some activity at low doses and decreased its in situ
activity at high doses.21
In Vitro Activation of Proteasome With Core
Protein
To determine whether core protein directly affects
proteasome activity in vitro (in the absence of oxidants),
we incubated purified 20S proteasome with core pro-
tein, as detailed in the Materials and Methods section.
The purity of core protein was confirmed (shown in
Figure 4A). However, we utilized 2 different proteasome
preparations. One preparation (Pr. 1) contained both 20S
proteasome as well as the proteasome activator PA28, as
revealed by Western blot analysis (Figure 4B). The other
preparation (Pr. 2) had undetectable levels of PA28 (Fig-
ure 4B). We observed that the core protein caused a
dose-dependent activation of the proteasome only with
Pr. 1 preparation and not with Pr. 2 (Figure 4C). Such
activation was rather specific for core protein because the
addition of the same mass of bovine serum albumin or
Figure 2. (A) Effects of ethanol on L-14 cells. Cells were treated or not
with 50 mmol/L ethanol for 72 hours. Proteasome activity was mea-
sured by in situ assay. Data from 4 independent experiments are pre-
sented as percent of control proteasome activity in tetracycline-
untreated and -treated cells. *Indicates a significant difference (P .05)
between proteasome activity in control (untreated cells) and ethanol-
treated cells. (B) Effects of ethanol on L-14 cells in the presence of
glutathione precursors, GSH-EE and N-acetyl cysteine (NAC), and eth-
anol metabolism inhibitors. Tetracycline-untreated L-14 cells were ex-
posed to 50 mmol/L ethanol in the presence or absence of catalase,
DAS, or GSH-EE at the indicated concentrations for 72 hours. Protea-
some activity was measured by in situ assay. Data from 3 independent
experiments are presented as percent of control proteasome activity in
ethanol-untreated L-14 cells. *Indicates a significant difference between
control and treated cells.
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recombinant NS3 protein (Virogen, Inc, Watertown, MA)
failed to activate Pr. 1 preparation (Figure 4C). The effect of
HCV core protein on proteasome preparation was similar to
the effect of commercially available HCV core protein (Vi-
rogen, Inc) on commercially available 20S proteasome ob-
tained from Boston Biochem (Figure 4C). Thus, Pr. 1 prep-
aration was used in all subsequent in vitro incubations.
Effects of Mitochondria and Microsomes on
Proteasome Activation by Core Protein
It has been reported that in vivo, HCV core pro-
tein associates with the mitochondrial membrane.4,5
Therefore, we examined the effects of isolated mitochon-
dria on the 20S proteasome activity modulation by HCV
core on the premise that the core protein might function
in association with other mitochondrial components. Pr.
1 was incubated with core protein as well as mitochon-
drial preparations obtained from livers of control or
ethanol-fed C57Bl/6 mice. Inclusion of 30 g mitochon-
drial protein in the incubation mixture (containing 300
pg core) enhanced the activation of proteasome by core
protein up to 6.3-fold (Figure 5A). In contrast, a 3.2-fold
increase in proteasome activation was observed when
mitochondria fractions from ethanol-fed mice were used.
This indicates a blunted response with mitochondria
from ethanol-fed mice (Figure 5A). No differences were
observed between freshly isolated and frozen mitochon-
dria on core protein-induced proteasome activation. Fur-
thermore, only mitochondria protein used at a 10-g
level significantly enhanced the activating effect of re-
combinant PA28, which, by itself, increased proteasome
activity by 1.8-fold (Figure 5B).
In cells, core protein is associated not only with mito-
chondria but also with the ER membrane. To determine
the effects of ER preparations (ie, microsomes) on core-
mediated proteasome activation, we conducted similar
experiments as with mitochondrial fractions. A 2.3-fold
increase in proteasome activity was observed when mi-
crosomes from control mice were incubated in the pres-
ence of core protein and Pr. 1 proteosome preparation
(Figure 5A). Microsomes combined with mitochondria
caused a 7.4-fold elevation of proteasome activity. Pro-
teasome activation was again attenuated when micro-
somes from ethanol-fed mice were used with core protein
(1.5-fold stimulation). Moreover, there was no further
elevation of proteasome activity when microsomes and
Figure 4. (A) HPLC purification of core protein. Samples were sub-
jected to SDS-PAGE and visualized by coomassie blue stain (lanes 1
and 2) or immunoblot for core protein (lane 3). Lane 1: lysed bacterial
cell pellet; lane 2: purified HCVC 179; lane 3: purified HCVC 179. (B)
Expression of PA28 subunits in various proteasome preparations (Pr. 1,
proteasome 1; Pr. 2, proteasome 2; BB, proteasome from Boston
Biochem). A representative blot is presented for 2 proteasome prepa-
rations that were obtained as described then subjected to Western blot
analysis. 20S proteasome preparations (Pr. 1 and Pr. 2) were probed for
PA28 , , and  using specific antibodies (Biomol International). BB
proteasome preparations and crude cytosolic proteasome preparation
were used as controls. (C) Effects of core protein on proteasome activity
in 2 proteasome preparations. 20S proteasome (Pr. 1 and Pr. 2) prep-
arations were incubated with 100, 200, and 300 pg core protein for 5
minutes at 25°C and with 300 pg bovine serum albumin or NS3 protein.
Proteasome activity was then detected by Suc-LLVY-AMC hydrolysis.
Data from 3 experiments are presented as percent of 20S proteasome
activity. As the control, exposure of commercial HCV core protein (Vi-
rogen, Inc) to commercial 20S proteasome (Boston Biochem) was used
(Pr. 1, open bars; Pr. 2, solid bars; BB, shaded bars). Columns with
different letters are significantly different from each other, and columns
with the same letters are not.
Figure 3. Effects of various concentrations of t-BOOH on proteasome
activity in core 191-20 cells. Cells were exposed to indicated concen-
trations of t-BOOH for 5 hours, and then proteasome activity was mea-
sured by in situ assay. Data from 2 experiments are presented as
specific proteasome activity, nmol/g DNA. *Indicates a significant dif-
ference (P  .05) between control and treated cells.
B
A
SIC
–LIV
ER
,
P
A
N
C
R
EA
S,
A
N
D
B
ILIA
R
Y
TR
A
C
T
2148 OSNA ET AL GASTROENTEROLOGY Vol. 134, No. 7
mitochondria from ethanol-fed mice were combined with
core protein (Figure 5A). Neither mitochondria nor mi-
crosomes by themselves possessed significant proteasome
activity (not shown).
Discussion
HCV core protein is degraded by the ubiquitin-
proteasome pathway, and E6AP has been identified as the
specific ubiquitin ligase that marks the protein for deg-
radation.22,23 Here, we demonstrated that core protein
also regulates proteasome activity, which potentially
would influence protein catabolism in HCV-infected
hepatocytes. Furthermore, this study identifies a dual
mechanism of core-mediated proteasome activation via
core protein-induced oxidant generation, as was revealed
from our cell culture experiments and evidence of cross
talk between core protein and PA28-20S complex sup-
ported by the cell-free studies.
As already demonstrated by others,6,7 191-20 and L-14
cells and core-expressing or nonexpressing mice had dif-
ferential levels of ROS production/GSH content in mi-
tochondria. Furthermore, Otani et al7 showed that the
ratio between pro- and antioxidative factors (ROS and
GSH, respectively) is lowest in core-positive 191-20 cells,
with a moderate increase in core-positive L-14 cells, fol-
lowed by an increase in ethanol and/or t-BOOH-treated
core-positive L-14 cells. Thus, in core-positive/CYP2E1-
negative cells, core protein caused predominant genera-
tion of oxidants in mitochondria, whereas, in CYP2E1-
expressing cells, oxidant generation was initiated by core
protein both at the mitochondrial and the ER levels and
was potentiated by ethanol treatment.
Here, we utilized the same cell lines, which were ex-
posed (or not) to ethanol, to create varying gradations of
oxidant stress. We presumed that the differential levels of
oxidant stress differentially regulated the proteasome ac-
tivity. To mimic this situation, we exposed core-positive
191-20 cells to various doses of the oxidant t-BOOH,
which, at low doses, increased proteasome function, and
at high doses suppressed proteasome activity. This find-
ings was not limited to t-BOOH, and similar results were
reported using various concentrations of hydrogen per-
oxide as well as the peroxynitrite donor SIN1 in HepG2
cells.21,24
Here, we observed enhanced proteasome activity in
both core-positive 191-20 and L-14 cells, with a much
higher magnitude of proteasome activation in CYP2E1-
expressing L-14 cells. These results, taken together with
previous reports of low to moderate ROS generation/
GSH depletion in core-positive 191-20 and L-14 cells,7
indicated that these levels of oxidative stress activate
proteasome. This conjecture was confirmed by data that
showed that treatment with GSH analogs/precursors re-
versed core-induced proteasome activation in both cell
lines. In addition, inclusion of antioxidants (uric acid or
catalase) or the CYP2E1 inhibitor DAS lowered protea-
some activity in CYP2E1-positive/core-positive L-14 cells
to approach the same levels in core-negative cells. How-
ever, when L-14 cells were exposed to ethanol (portending
a much higher level of oxidant generation), proteasome
activity was suppressed. Indeed, a reciprocal relationship
between CYP2E1 expression and proteasome activity has
been previously reported,10,25,26 and we have also shown a
decline in proteasome function by ethanol exposure.12,27
The mechanism of this decline in proteasome activity can
Figure 5. (A) The effects of mitochondria and microsomes on core-
activated 20S proteasome activity. Mitochondrial and microsome frac-
tions were obtained from livers of control and ethanol-fed mice. 20S
proteasome was incubated with 300 pg core protein and an equal
mixture of mitochondrial and microsomal proteins (see Materials and
Methods section). Proteasome activity was then assayed. Data from 3
experiments are expressed as percent of 20S proteasome activity with
core protein alone. Bar columns with different letters are significantly
different from each other, and columns with the same letters are not. By
themselves, mitochondria and microsomes possess little-to-no protea-
some activity (not shown). (B) Effects of mitochondria  core on 20S
proteasome after addition of recombinant PA28. 20S proteasome
(Pr.1) was exposed to PA28 in the presence or absence of core protein
and of mitochondria isolated from livers of control (MitoC) or ethanol-fed
(MitoE) mice (100 pg core/10 g mitochondria). Data from 3 experi-
ments are expressed as percent of 20S proteasome activity (without
additions). Bar columns with different letters are significantly different
from each other, and columns with the same letters are not.
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be attributed, in part, to the inability of PA28 to activate
the 20S enzyme when proteasome is heavily oxidatively
modified, although low amounts of oxidants facilitate
the 20S-PA28 interactions.21
However, even in the absence of oxidative stress, core
protein was able to activate 20S proteasome, which
formed the complex with PA28 and . This means that,
in addition to indirect core-mediated regulation of pro-
teasome activity via oxidant stress, the possibility of di-
rect core-proteasome interactions cannot be excluded. To
clarify whether core protein also affects proteasome func-
tion via direct protein-proteasome interactions, we used a
cell-free system, in which proteasome is exposed to core
protein in the absence of oxidative stress. We observed a
link between activating effects of core protein only on
20S proteasome copurified with PA28 subunits, indicat-
ing that core protein affected 20S proteasome activity by
facilitating its interaction with assembled PA28 (, , and
 subunits). In fact, PA28, and to a lesser extent , are
known as classical activators of 20S proteasome chymot-
rypsin-like activity in the cytosol, and  subunit regu-
lates proteasome trypsin-like activity, mainly, in the nu-
cleus.28,29 In our study, PA28-20S proteasome complex
responded to core protein by increased chymotrypsin-like
activity, whereas, as reported earlier, core protein forms a
complex with PA28 but not with PA28 and .30 How-
ever, even if core protein initially attaches to PA28, we
cannot exclude that  subunit subsequently activates 
subunit in PA28-20S proteasome preparation, thereby
increasing chymotrypsin-like proteasome activity. This
core-induced proteasome activation was further en-
hanced by addition of exogenous recombinant PA28.
In HCV-expressing cells, core protein is located be-
tween the outer mitochondrial membrane and the ER.6
To mimic this cellular interaction in a cell-free system, we
measured whether proteasome activation by core protein
was further modulated by mitochondria and/or micro-
somes. Each subcellular fraction, either alone or in com-
bination, potentiated proteasome activation by core pro-
tein. The activating effect of mitochondria was not
dependent on their structural integrity because both fro-
zen and freshly isolated mitochondrial preparations
equally enhanced core protein-mediated 20S proteasome
activation. Therefore, proteasomal activation was likely
the result of interactions between 20S-PA28 complex and
specific mitochondrial protein(s), possibly, in/on the
outer membrane. This is consistent with findings of oth-
ers that core protein has a strong tendency to associate
with various proteins, such as STAT1 and Jaks, affecting
their functions.31,32 Interestingly, the cross talk between
core-activated proteasome and mitochondria or/and mi-
crosomes was blunted in the presence of mitochondria or
microsomes from ethanol-fed mice, indicating that eth-
anol-induced dysregulation of protein expression in these
organelles may be attributed to their adduction by oxi-
dants.
The nature of the putative proteasome-interacting pro-
tein(s) in mitochondria and ER is not clear. Heat shock
proteins (HSP) are potential candidates for providing com-
munication between mitochondria, microsomes, and the
proteasome because the role of HSP in interactions between
the microsomal enzyme CYP2E1 and the proteasome has
been established.33 Mitochondriamay also affect the activity
of 20S-PA28 complex via interactions between mitochon-
drial HSP70 and PA28 because mitochondria express
HSP7034 and the association between HSP70 and PA28
during substrate refolding has been reported.35
The physiologic and pathogenic relevance of proteasome
activation by core protein is in an enhanced ability of
proteasome to cleave the substrate proteins. Because some
HCV proteins (such as NS5B as well as nuclear core protein)
are targeted by proteasome,36 their rapid degradation may
be favorable for HCV elimination. However, these proteins,
in turn, form stable complexes with other important signal-
ing proteins, thereby facilitating the removal of HCV-sig-
naling factor complexes by proteasome. For example, in
HCV protein-expressing cells, the depletion of STAT1, a
signal transduction factor for interferons, may be poten-
tially attributed to enhanced proteasome function as dem-
onstrated by suppression of STAT1 disappearance in the
presence of the proteasome inhibitor, MG132.37 Similarly,
activation of proteasome by viral proteins leads to degrada-
tion of protective factors, as observed in other viral infec-
tions.38 However, even if core protein enhances proteasome
activity, this may not result in tremendously increased gen-
eration of peptides for MHC class I-restricted antigen pre-
sentation because the most antigen-processing enzymes (in-
cluding proteasome) are activated by interferon, and, to be
effective, peptide processing requires unaltered interferon
signaling, whereas STAT1 is degraded by the proteasome. If
core-positive/CYP2E1-expressing liver cells are exposed to
ethanol, ethanol metabolism suppresses proteasome activ-
ity. This may prevent the degradation of the “protective”
proteins, such as STAT1, but will ultimately block STAT1
phosphorylation.27 The processing of viral peptides for an-
tigen presentation by liver cells will be further suppressed
because, in this case, ethanol metabolism not only sup-
presses proteasome-dependent cleavage of antigenic pep-
tides but also prevents interferon signaling by altering
STAT1 phosphorylation. The outcomes of core-induced
proteasome activation and the suppressing effects of etha-
nol exposure for innate and adaptive immunity, as well as
the identification of proteins involved in HCV core-protea-
some-mitochondrion-ER interactions, will be the subject of
future investigations. A proposed mechanism of core-pro-
teasome interactions in liver cells is depicted in Figure 6.
In summary, HCV core protein enhanced 20S protea-
some activity directly, by facilitating interactions among
20S proteasome, PA28, and mitochondria/microsomes
and, indirectly, via generation of low levels of oxidants.
Elevated oxidant generation by ethanol metabolism and
disruption of core-20S-PA28-mitochondrial interactions
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ultimately results in reduced liver proteasome activity
that may influence the propagation of HCV clinical
course in alcoholic patients.
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